APT Medical Inc.
Research APT Medical Inc. (688617.SS) on Bullrun: market cap CNY 35.28B, P/E 37.2, dividend yield 0.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker688617.SS
- ExchangeSS
- CountryChina
- SectorHealthcare
- IndustryMedical Devices
- CurrencyCNY
- Market capCNY 35.28B
- P/E37.2
- Dividend yield0.4%
- Financial periodQ2 2026
- RevenueCNY 822.27M
- Net incomeCNY 307.88M
- Free cash flowCNY 333.43M
- Gross margin73.4%
Valuation Snapshot
latest market cap is CNY 35.28B; P/E is 37.2; dividend yield is 0.4%.
Peer valuation comparison
Latest P/E is 37.15x versus a Healthcare sector median of 21.8x (70.5% above).
Latest dividend yield is 0.36% versus a Healthcare sector median of 2.4% (85.0% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | CNY 35.28B | 37.2 | 0.4% | 1 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1 CNY, yield 0.4%.
About APT Medical Inc.
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagnostic products, therapeutic products, and accessories.
ETFs that hold APT Medical Inc.
US-listed ETFs
APT Medical Inc. is held by 28 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| iShares MSCI Emerging Markets ETF (EEM) | <0.01% | 0.72% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| iShares MSCI ACWI ETF (ACWI) | <0.01% | 0.32% |
| iShares MSCI ACWI ex U.S. ETF (ACWX) | <0.01% | 0.32% |
| Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU) | <0.01% | 0.04% |
| Schwab Emerging Markets Equity ETF (SCHE) | <0.01% | 0.06% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is APT Medical Inc.'s market cap?
APT Medical Inc.'s market capitalization is CNY 35.28B.
What is APT Medical Inc.'s P/E ratio?
APT Medical Inc.'s price-to-earnings (P/E) ratio is 37.2.
Does APT Medical Inc. pay a dividend?
APT Medical Inc. has a dividend yield of 0.4%.
What does APT Medical Inc. do?
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagnostic products, therapeutic products, and accessories. The company also manufactures and supplies EP and vascular intervention medical devices.